Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RSV anticorps

L’anticorps anti-RSV Polyclonal Lapin est utilisé pour la détection de RSV dans des échantillons de Respiratory Syncytial Virus (RSV). Il a été validé pour WB.
N° du produit ABIN437960
449,63 €
Plus frais de livraison 40,00 € et TVA
0.1 mL
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour RSV anticorps (ABIN437960)

Antigène

RSV (Respiratory Syncytial Virus (RSV))

Reactivité

  • 70
  • 13
  • 13
  • 13
Respiratory Syncytial Virus (RSV)

Hôte

  • 40
  • 25
  • 20
Lapin

Clonalité

  • 40
  • 39
Polyclonal

Conjugué

  • 42
  • 12
  • 9
  • 7
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp RSV est non-conjugé

Application

  • 42
  • 24
  • 23
  • 20
  • 13
  • 13
  • 11
  • 10
  • 8
  • 8
  • 8
  • 6
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Purification

    Aff - Purified

    Immunogène

    Whole RSV virions (subgroup A-Long strain) were used as an immunogen. Detects G, F, N and M2 proteins of RSV.

    Isotype

    IgG
  • Indications d'application

    Optimal working dilutions should be determined experimentally by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Stock

    -20 °C
  • Antigène

    RSV (Respiratory Syncytial Virus (RSV))

    Classe de substances

    Virus

    Sujet

    RSV is a negative sense RNA paramyxovirus in which the major virus neutralization antigens are the glycoprotein (G) and the fusion (F) protein that mediate attachment and fusion to the host cell during virus infection, respectively. Other RSV proteins include the nucleocapsid protein (N) and the M2 protein. The two major subgroups of RSV are A and B with the A strain being more virulent and responsible for the majority of severe RSV infections. Respiratory syncytial virus (RSV) infection is responsible for a large proportion of viral respiratory infections, and significant morbidity is associated with RSV infections. To date, few RSV vaccine candidates have shown promise with no human vaccine yet been proven safe and efficacious.
Vous êtes ici:
Chat with us!